Growth Metrics

Dare Bioscience (DARE) Cash from Operations (2016 - 2025)

Dare Bioscience's Cash from Operations history spans 11 years, with the latest figure at 1444264.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 72.78% year-over-year to 1444264.0; the TTM value through Dec 2025 reached 9885870.0, down 280.61%, while the annual FY2025 figure was 9885870.0, 280.61% down from the prior year.
  • Cash from Operations reached 1444264.0 in Q4 2025 per DARE's latest filing, up from 430134.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 12904685.0 in Q2 2024 to a low of 16117571.0 in Q1 2023.
  • Average Cash from Operations over 5 years is 4506071.75, with a median of 6255216.5 recorded in 2023.
  • Peak YoY movement for Cash from Operations: skyrocketed 551.37% in 2022, then plummeted 192.72% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 9915899.0 in 2021, then skyrocketed by 40.53% to 5896672.0 in 2022, then crashed by 38.7% to 8178905.0 in 2023, then surged by 164.87% to 5305918.0 in 2024, then tumbled by 72.78% to 1444264.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Cash from Operations are 1444264.0 (Q4 2025), 430134.0 (Q3 2025), and 5400000.0 (Q2 2025).